Lv1
90 积分 2023-04-01 加入
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
7天前
已完结
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
7天前
已关闭
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
7天前
已完结
Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia
7天前
已关闭
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia
7天前
已完结
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
7天前
已完结
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia
8天前
已完结
The spectrum of hematologic neoplasms in patients with Li‐Fraumeni syndrome
9天前
已完结
Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast‐phase BCR::ABL1‐negative myeloproliferative neoplasms
9天前
已完结
Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis
9天前
已完结
皖公网安备34019202002308
